Search research articles
Contact Us
Filters
Showing results (201-210 of 227) with videos related to
Page
of 23
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
February 23, 2024
Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma
Hyunseok Yoon, Yeokyeong Shin, Baek-Yeol Ryoo, et al.
Cancer Research and Treatment
|
November 10, 2020
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients
Jwa Hoon Kim, Jae Ho Jeong, Baek-Yeol Ryoo, et al.
Cancers
|
March 1, 2019
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
Changhoon Yoo, Sang Hyun Shin, Kyu-Pyo Kim, et al.
Anticancer Research
|
February 10, 2017
Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin
Sunmin Park, Song Cheol Kim, Seung-Mo Hong, et al.
Investigational New Drugs
|
April 5, 2018
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
Jihoon Kang, Inhwan Hwang, Changhoon Yoo, et al.
Therapeutic Advances in Medical Oncology
|
September 28, 2020
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
Changhoon Yoo, Inhwan Hwang, Tae Jun Song, et al.
Therapeutic Advances in Medical Oncology
|
May 16, 2022
Real-world outcomes of adjuvant gemcitabine <i>versus</i> gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
Sora Kang, Changhoon Yoo, So Heun Lee, et al.
Cancer Research and Treatment
|
March 14, 2023
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, et al.
Asia Pacific Journal of Clinical Nutrition
|
August 14, 2017
Postoperative oral nutritional supplementation after major gastrointestinal surgery: a randomized controlled clinical trial
Seong-Ho Kong, Jun Seok Park, In Kyu Lee, et al.
Neuroendocrinology
|
October 1, 2020
Risk Factors for Recurrence in Pancreatic Neuroendocrine Tumor and Size as a Surrogate in Determining the Treatment Strategy: A Korean Nationwide Study
Wooil Kwon, Jin-Young Jang, Ki Byung Song, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 227) with videos related to
Sort By:
Page
of 23
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
February 23, 2024
Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma
Hyunseok Yoon, Yeokyeong Shin, Baek-Yeol Ryoo, et al.
Cancer Research and Treatment
|
November 10, 2020
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients
Jwa Hoon Kim, Jae Ho Jeong, Baek-Yeol Ryoo, et al.
Cancers
|
March 1, 2019
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
Changhoon Yoo, Sang Hyun Shin, Kyu-Pyo Kim, et al.
Anticancer Research
|
February 10, 2017
Postoperative Radiotherapy for Pancreatic Cancer with Microscopically-positive Resection Margin
Sunmin Park, Song Cheol Kim, Seung-Mo Hong, et al.
Investigational New Drugs
|
April 5, 2018
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
Jihoon Kang, Inhwan Hwang, Changhoon Yoo, et al.
Therapeutic Advances in Medical Oncology
|
September 28, 2020
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
Changhoon Yoo, Inhwan Hwang, Tae Jun Song, et al.
Therapeutic Advances in Medical Oncology
|
May 16, 2022
Real-world outcomes of adjuvant gemcitabine <i>versus</i> gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
Sora Kang, Changhoon Yoo, So Heun Lee, et al.
Cancer Research and Treatment
|
March 14, 2023
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, et al.
Asia Pacific Journal of Clinical Nutrition
|
August 14, 2017
Postoperative oral nutritional supplementation after major gastrointestinal surgery: a randomized controlled clinical trial
Seong-Ho Kong, Jun Seok Park, In Kyu Lee, et al.
Neuroendocrinology
|
October 1, 2020
Risk Factors for Recurrence in Pancreatic Neuroendocrine Tumor and Size as a Surrogate in Determining the Treatment Strategy: A Korean Nationwide Study
Wooil Kwon, Jin-Young Jang, Ki Byung Song, et al.
Page
of 23